Pediatric ERAS Approach for Intestinal Resection with Primary Connection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter prospective study in nine Polish pediatric centers evaluates the feasibility, safety, and clinical outcomes of a standardized pediatric ERAS protocol for elective intestinal resection with primary anastomosis. Fifty-nine or fewer patients are planned to be enrolled to receive care per the ERAS protocol, with outcomes compared to a historical control group. The protocol covers multimodal analgesia, early feeding and mobilization, and avoidance of unnecessary tubes and drains, aiming to reduce recovery time and complications. The study builds on prior ERAS work in adults and adapts it for the pediatric population. Data will help determine if a pediatric ERAS pathway can be safely implemented and improve perioperative results.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients younger than 18 years
* Patients undergoing elective intestinal resection with primary anastomosis
* Patients treated in participating pediatric surgery departments
* Patients managed according to the standardized pediatric ERAS-based protocol after its implementation in participating centers

Exclusion Criteria:

* Patients treated outside pediatric surgery departments
* Patients requiring total parenteral nutrition prior to surgery
* Emergency surgical procedures
* Patients with Hirschsprung disease
* Resection with stoma formation, or creation of a protective/diverting stoma during the index operation
* Patients with incomplete clinical data

Where it's running

• Wroclaw Medical University, Wrocław, Poland. Clinical Department of Paediatric Cardiosurgery, Surgery and Urology
  Wroclaw, Lower Silesian Voivodeship, Poland Recruiting
• Medical University of Lublin, Poland. Department of Pediatric Surgery and Traumatology, University Children's Hospital
  Lublin, Lublin Voivodeship, Poland Recruiting
• University Clinical Center, Medical University of Warsaw, Poland. Department of Pediatric Surgery, Pediatric Urology and Pediatrics
  Warsaw, Masovian Voivodeship, Poland Recruiting
• Jagiellonian University Medical College, University Children's Hospital of Krakow, Poland. Department of Pediatric Surgery
  Krakow, Małopolska, Poland Recruiting
• Medical University of Gdansk, Poland. Department of Surgery and Urology for Children and Adolescents
  Gdansk, Pomeranian Voivodeship, Poland Recruiting
• Medical University of Silesia, Katowice, Poland. Department of Children's Developmental Defects Surgery and Traumatology
  Zabrze, Upper Silesia, Poland Recruiting

Study contacts

• Principal investigator: Michal Pasierbek, M.D. Ph.D. — Medical University of Silesia, Katowice, Poland. Department of Children's Developmental Defects Surgery and Traumatology, Zabrze, Upper Silesia 41-800
• Study coordinator: Michał J Pasierbek, M.D. Ph.D.
• Email: michal.pasierbek@sum.edu.pl
• Phone: +48 500 089 727

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Signia circular stapler for left-sided colon, sigmoid, and rectal resections

  This study will try the Signia circular stapler with Tri-Staple technology to see if it safely creates bowel reconnections in adults having left-sided colon, sigmoid, or rectal surgery.

  Recruiting at 6 sites Medtronic - MITG · New Haven, Connecticut and 9 other locations · NCT07351071

• PF-08634404 plus chemotherapy for adults with metastatic colorectal cancer

  This trial will test whether adding a new drug called PF-08634404 to standard chemotherapy helps adults whose colorectal cancer has spread.

  Recruiting at 343 sites Phase 3 Pfizer · Chandler, Arizona and 371 other locations · NCT07222800

• Comparing a low-FODMAP diet program versus exposure-based cognitive behavioral therapy for people with IBS

  This project will test whether an online low-FODMAP diet program or an online exposure-based cognitive behavioral therapy better reduces IBS symptoms in adults.

  Recruiting University of Melbourne · Melbourne, Victoria · NCT06940596

• Pooling clinical experiences of patients treated with Lutetium-177 in Spain

  This study looks at how well Lutetium-177 works and how safe it is for patients with certain types of tumors in Spain by collecting information from their medical records.

  Recruiting at 11 sites Sociedad Española de Medicina Nuclear e Imagen Molecular · Santiago de Compostela, A Coruña and 19 other locations · NCT04949282

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.